• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TUTOGEN MEDICAL, GMBH DURAFLEX DURAL GRAFT; BOVINE PERICARDIUM DURAL SUBSTITUTE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TUTOGEN MEDICAL, GMBH DURAFLEX DURAL GRAFT; BOVINE PERICARDIUM DURAL SUBSTITUTE Back to Search Results
Catalog Number BP10405
Device Problems Material Disintegration (1177); Material Puncture/Hole (1504); Material Rupture (1546)
Patient Problems Cerebrospinal Fluid Leakage (1772); Failure of Implant (1924)
Event Date 09/16/2023
Event Type  Injury  
Manufacturer Narrative
A comprehensive records re-review will be conducted.Once the results are available, a follow-up report will be submitted.
 
Event Description
Rti surgical inc.(rti) received a complaint on 09/25/2023.The reported complaint indicated that the patient had a chiari malformation and underwent a surgical procedure with implantation of an integra duraflex suturable graft (lot # is unknown) on (b)(6) 2023.On (b)(6) 2023, the patient underwent emergency surgery for incision and drainage procedure in the posterior neck due to a cerebrospinal fluid leak.During the procedure, visual examination of the graft showed the graft had thinned out and leakage was present in the middle or the interior portion of the graft; the graft had dissolved in the middle.(voluntary report mw5146289).A second integra duraflex suturable graft was then implanted (lot # nza19460204; manufacturer report 3002719998-2023-00019; voluntary mw5146291).The graft weakened in the middle during implantation and was removed.A third integra duraflex suturable graft was then implanted (lot # nza22040112; manufacturer report 3002719998-2023-00020; voluntary report mw5146291) which also dissolved in the middle and was explanted.Lastly, a duragen® suturable graft (not manufactured by rti) was implanted.On (b)(6) 2023, the patient underwent additional intervention due to the deterioration of the duragen® implant near the suture line.The holes around the suture line had enlarged resulting in the graft being explanted and replaced with a new product (brand and manufacturer are unknown).To date, no additional information has been provided to rti for review.
 
Manufacturer Narrative
The graft was discarded at the facility and not available for evaluation at rti.No unique serial id or lot number was provided; therefore, a comprehensive re-review of the batch record could not be performed.Although implant therapy is highly successful and predictable, it is not without possible early and/or late complications.Examples include decreased blood supply at the surgical site, poor soft tissue coverage, weight, infection, poor glycemic control, medications (e.G.Steroids), physical location of the surgical site, allergic reactions to bovine material, bacterial or viral infection, inflammation, or non-adherence to implant package insert instructions.Cumulative risk factors increase the likelihood of complications.Additional information is needed to better understand and possibly explain the reported complications.Information regarding membrane rehydration process prior to use, suture procedure and suture material utilized, whether the membranes were fixated under tension, other products used in the case (sealants), and if the patient had an allergy to bovine collagen and/or bovine material.It is more plausible that the patient's adverse event is associated with a source or event extrinsic to the duraflex graft.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DURAFLEX DURAL GRAFT
Type of Device
BOVINE PERICARDIUM DURAL SUBSTITUTE
Manufacturer (Section D)
TUTOGEN MEDICAL, GMBH
industriestrasse 6
neunkirchen am brand, deu 91077
GM  91077
Manufacturer Contact
karen britt
11621 research circle
alachua, FL 32615
3865186607
MDR Report Key18015702
MDR Text Key326649689
Report Number3002719998-2023-00018
Device Sequence Number1
Product Code GXQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K132850
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Distributor
Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date 12/28/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/26/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberBP10405
Device Lot NumberNOT PROVIDED
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/25/2023
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-